Eletriptan Hydrobromide Tablet, Film Coated
Product Images NDC 24689-167

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eletriptan Hydrobromide (NDC 24689-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apnar Pharma Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure diagram of eletriptan hydrobromide, showing its molecular components and arrangement.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
A line graph titled 'Estimated Probability of Initial Headache Response Within 2 Hours' showing the estimated probability of response over time from 0 to 2 hours after initial dose. The graph compares double blind placebo with eletriptan at 20 mg, 40 mg, and 80 mg doses using distinct dashed lines and symbols, illustrating increased probability of headache response at higher doses over the 2-hour period.*
FDA Label Image

Figure 2 (Image 03)

Figure 2 (Image 03)
A line graph titled 'Estimated Probability of Taking a Second Dose/Other Medication Over the 24 Hours Following the First Dose' showing probability on the y-axis (0.0 to 0.9) and time from initial dose in hours on the x-axis (0 to 24 hours). Four lines represent data for double blind placebo, eletriptan 20 mg, eletriptan 40 mg, and eletriptan 80 mg, depicting the probability trends of taking a second dose or other medication over time.*
FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Pack)

Principal Display Panel (20 mg Tablet Bottle Pack)
Eletriptan Hydrobromide Tablets 20 mg film-coated oral tablets label. The label indicates Rx only with a quantity of 100 tablets. Manufactured by Beximco Pharmaceuticals Ltd, Bangladesh, and distributed by Apnar Pharma LP, Chino, CA, USA. Storage instructions and dosage information are provided.*
FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Pack)

Principal Display Panel (40 mg Tablet Bottle Pack)
Eletriptan Hydrobromide Tablets 40 mg film-coated tablet label. The label shows strength as 40 mg, package of 100 tablets, and indicates prescription use only. Manufactured by Beximco Pharmaceuticals Ltd. in Bangladesh and distributed by Apnar Pharma LP in Chino, CA, USA. Storage instructions and dosage information references are provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.